Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.92 USD | -0.52% | -4.00% | -18.30% |
May. 09 | Transcript : Xeris Biopharma Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (XERS) XERIS BIOPHARMA HOLDINGS Reports Q1 Revenue $40.6M, vs. Street Est of $41.8M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.30% | 286M | |
+38.32% | 727B | |
-7.84% | 354B | |
+15.61% | 328B | |
+0.16% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.17% | 164B | |
-1.72% | 164B |
- Stock Market
- Equities
- XERS Stock
- News Xeris Biopharma Holdings, Inc.
- Xeris Biopharma Expects 2023 Revenue to be at High End of Previous Guidance; Shares Jump